122 related articles for article (PubMed ID: 10213280)
21. Cardiac effects of beta-adrenoceptor antagonists with intrinsic sympathomimetic activity in humans: beta1- and/or beta2-adrenoceptor mediated?
Jakubetz J; Schmuck S; Poller U; Fuchs B; Gorf A; Radke J; Pönicke K; Brodde OE
J Cardiovasc Pharmacol; 1999 Mar; 33(3):461-72. PubMed ID: 10069683
[TBL] [Abstract][Full Text] [Related]
22. Effects of carvedilol on heart rate and blood pressure variability in subjects with chronic heart failure.
Piccirillo G; Luparini RL; Celli V; Moisè A; Lionetti M; Marigliano V; Cacciafesta M
Am J Cardiol; 2000 Dec; 86(12):1392-5, A6. PubMed ID: 11113424
[TBL] [Abstract][Full Text] [Related]
23. Captopril adjuvant therapy to beta-blockers and nitrates improves post-myocardial infarction left ventricular performance.
Kyriakidis M; Antonopoulos A; Georgiou E; Santas P; Bakirtzis C; Toutouzas P
Eur Heart J; 1996 Jun; 17(6):864-73. PubMed ID: 8781825
[TBL] [Abstract][Full Text] [Related]
24. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
25. [Use of selective long-acting beta-blocker with vasodilating activity celiprolol in patients with essential hypertension].
Podzolkov VI; Mozharova LG
Kardiologiia; 2002; 42(10):22-6. PubMed ID: 12494052
[TBL] [Abstract][Full Text] [Related]
26. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy.
Wisenbaugh T; Katz I; Davis J; Essop R; Skoularigis J; Middlemost S; Röthlisberger C; Skudicky D; Sareli P
J Am Coll Cardiol; 1993 Apr; 21(5):1094-100. PubMed ID: 8096228
[TBL] [Abstract][Full Text] [Related]
27. Comparative cardiac haemodynamics of bisoprolol, celiprolol, carvedilol and nebivolol in normal volunteers.
De Cree J; Van Nueten L; Geukens H; Verhaegen H
Int J Clin Pharmacol Res; 1992; 12(4):159-63. PubMed ID: 1363660
[TBL] [Abstract][Full Text] [Related]
28. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy.
Metra M; Nardi M; Giubbini R; Dei Cas L
J Am Coll Cardiol; 1994 Dec; 24(7):1678-87. PubMed ID: 7963115
[TBL] [Abstract][Full Text] [Related]
29. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy.
Currie PJ; Kelly MJ; McKenzie A; Harper RW; Lim YL; Federman J; Anderson ST; Pitt A
J Am Coll Cardiol; 1984 Jan; 3(1):203-9. PubMed ID: 6140277
[TBL] [Abstract][Full Text] [Related]
30. Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule.
Strein K; Sponer G
Z Kardiol; 1990; 79 Suppl 3():89-98. PubMed ID: 1983054
[TBL] [Abstract][Full Text] [Related]
31. Acute influence of beta-adrenergic antagonists on left ventricular diastolic function: contrasting results after administration of celiprolol and metoprolol.
Modersohn D; Franz N; Heublein B; Panzner B; Walde T; Bruch L
J Hum Hypertens; 1994 Feb; 8(2):127-32. PubMed ID: 7911530
[TBL] [Abstract][Full Text] [Related]
32. Effect of beta-blockade on baroreceptor and autonomic function in heart failure.
Sanderson JE; Yeung LY; Chan S; Tomlinson B; Kay R; Woo KS; Bernardi L
Clin Sci (Lond); 1999 Feb; 96(2):137-46. PubMed ID: 9918893
[TBL] [Abstract][Full Text] [Related]
33. Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy.
Woodley SL; Gilbert EM; Anderson JL; O'Connell JB; Deitchman D; Yanowitz FG; Mealey PC; Volkman K; Renlund DG; Menlove R
Circulation; 1991 Dec; 84(6):2426-41. PubMed ID: 1683602
[TBL] [Abstract][Full Text] [Related]
34. Characteristic of fibrotic myocardial lesions associated with life-threatening ventricular tachyarrhythmias in patients with ischemic and non-ischemic cardiomyopathies.
Shlevkov NB; Zhambeev AA; Gasparyan AZ; Shitov VN; Stukalova OV
Ter Arkh; 2018 Sep; 90(9):42-47. PubMed ID: 30701734
[TBL] [Abstract][Full Text] [Related]
35. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
Sinagra G; Perkan A; Di Lenarda A; Lardieri G; Pinamonti B; Mestroni L; Miani D; Camerini F
G Ital Cardiol; 1992 Aug; 22(8):969-89. PubMed ID: 1362167
[TBL] [Abstract][Full Text] [Related]
36. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
Doughty RN; Whalley GA; Gamble G; MacMahon S; Sharpe N
J Am Coll Cardiol; 1997 Apr; 29(5):1060-6. PubMed ID: 9120160
[TBL] [Abstract][Full Text] [Related]
37. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
[TBL] [Abstract][Full Text] [Related]
38. Daytime-selective antihypertensive activity of celiprolol.
Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH
Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
[TBL] [Abstract][Full Text] [Related]
39. Acute effects of celiprolol on angiographically normal and stenotic coronary arteries.
Jost S; Hausmann D; Lippolt P; Sturm M
Cardiovasc Drugs Ther; 1997 Apr; 11(2):133-8. PubMed ID: 9140690
[TBL] [Abstract][Full Text] [Related]
40. [Clinical effects of bisoprolol in congestive heart failure due to dilated cardiomyopathy].
Li Z; Li L
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):683-6. PubMed ID: 8731831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
